Genvor IncOTCQB:GNVR
- LAST PRICE3.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0000/ 21
- Ask / Lots3.5000/ 9
- Open / Previous Close0.0000 / 3.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Apr 22, 2024
Genvor to Unveil Latest Research on Patented Peptides for Aflatoxin Resistance in Corn at BioAgTech World Congress, from 8:32AM ET on Monday Apr 22, 2024 by Dow Jones
8:32AM ET on Monday Apr 22, 2024 by Dow Jones
Apr 2, 2024
Genvor to Participate in BioAgTech World Congress in Raleigh, North Carolina, from 8:32AM ET on Tuesday Apr 02, 2024 by Dow Jones
8:32AM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Genvor Inc | 60.3M | -19.8x | --- |
Moolec Science SA | 62.1M | -1.0x | --- |
Kaanapali Land LLC | 45.7M | 12.3x | --- |
Top Wealth Group Holding Ltd | 44.2M | 16.9x | --- |
Margo Caribe Inc | 36.2M | 5.6x | --- |
Local Bounti Corp | 25.0M | -0.2x | --- |
Company Information
Genvor Incorporated is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through biological foliar application as well as transgenic seed traits. The Company leverages its licensing-first business model with active trait developments for a variety of crops including corn, citrus, rice, cotton, soybean, flax and potato. Its solutions are designed to fight debilitating and deadly plant diseases, such as bacteria and fungi, in a broad spectrum of crop types through its library of patented anti-microbial peptides (AMPs). These AMPs can be applied to plants in the form of non-chemical seed traits (Transgenic seed traits), which imbue seeds with the desired traits, allowing plants to naturally produce AMPs, as well as a topical spray (Bio-pesticide) application.
Contact Information
- Headquarters
- 201 S. Elliott Road, Suite 538CHAPEL HILL, NC, United States 27514
- Phone
- 214-427-1921
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $60.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.15 |
Book Value | $-0.09 |
P/E Ratio | -19.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
